Blinatumomab before allogeneic stem cell transplantation: the ideal strategy to improve patient's outcomes?

Franco Locatelli1

  • 1Pediatric Haematology/Oncology and Cell and Gene Therapy Department - IRCCS, Bambino Gesù Children's Hospital, Rome, Italy; Department of Life Sciences, Catholic University of the Sacred Heart, Rome, Italy.

Abstract

No abstract available in PubMed .